IUGR Failure to Diagnose: Intrauterine Growth Restriction Lawsuits in NY

IUGR vs. SGA: Understanding the Difference

It is important to distinguish between IUGR and Small for Gestational Age (SGA) — terms that are often used interchangeably but have different meanings:

- SGA (Small for Gestational Age): A baby whose birth weight is below the 10th percentile for gestational age. This may be a constitutionally small but healthy baby (e.g., small parents, genetic factors). Not all SGA babies have IUGR.

- IUGR (Intrauterine Growth Restriction): A process in which the fetus fails to achieve its growth potential due to a pathological process (most commonly placental insufficiency). The baby may or may not be below the 10th percentile — a baby can have IUGR and still be above the 10th percentile if their genetic growth potential was higher. The key is a decline in growth velocity — the fetus was growing normally and then slowed or stopped.

This distinction is critical in malpractice cases. A provider who simply notes that the fetus is 'small' but doesn't investigate whether there is a pathological process causing the growth restriction may be missing IUGR. The standard of care requires that a fetus with decreased growth velocity — even if still above the 10th percentile — be evaluated for possible IUGR and its underlying causes.

Causes of IUGR

IUGR has many causes, which can be maternal, placental, or fetal:

• Placental insufficiency: The most common cause. The placenta fails to provide adequate oxygen and nutrients to the fetus. Often associated with maternal hypertension, preeclampsia, or vascular disease.
• Maternal hypertension/preeclampsia: High blood pressure reduces blood flow to the placenta. Preeclampsia is a leading cause of IUGR.
• Maternal vascular disease: Diabetes with vascular involvement, systemic lupus erythematosus (SLE), antiphospholipid syndrome, and other autoimmune conditions can impair placental blood flow.
• Maternal malnutrition: Severe nutritional deficiency can limit fetal growth.
• Maternal smoking, alcohol, or drug use: Toxins that cross the placenta and impair fetal growth.
• Infections: Cytomegalovirus (CMV), toxoplasmosis, rubella, syphilis, and other congenital infections can cause IUGR.
• Chromosomal abnormalities: Trisomy 13 (Patau syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 21 (Down syndrome) can cause IUGR.
• Structural abnormalities: Congenital heart defects, neural tube defects.
• Multiple gestation: Twins, triplets, or higher-order multiples — particularly monochorionic twins (twin-to-twin transfusion syndrome).
• Medications: Certain medications (antiepileptic drugs, some anticoagulants) can contribute to IUGR.

Placental Insufficiency: The Most Common Cause

Placental insufficiency is the most common cause of IUGR and is the primary focus of most malpractice cases. The placenta is the organ that delivers oxygen and nutrients from the mother to the fetus. When the placenta fails to function adequately — due to maternal hypertension, vascular disease, preeclampsia, or other factors — the fetus does not receive enough oxygen and nutrients to grow normally.

Placental insufficiency leads to a characteristic pattern called asymmetric IUGR: the fetus prioritizes brain growth (the 'brain-sparing effect'), so the head circumference is relatively preserved while the abdominal circumference (which reflects liver size and nutrient stores) lags behind. On ultrasound, the head-to-abdomen circumference ratio is elevated.

As placental insufficiency progresses, the fetus may develop: - Abnormal Doppler flow: Increased resistance in the umbilical artery (high pulsatility index, absent end-diastolic flow, or reversed end-diastolic flow) — indicating worsening placental function. - Oligohydramnios: Decreased amniotic fluid (the fetal kidneys produce less urine when blood flow is redirected to the brain). - Abnormal biophysical profile (BPP): Decreased fetal movement, breathing, tone, and amniotic fluid volume. - Fetal distress: Abnormal fetal heart rate patterns on monitoring.

The standard of care requires monitoring these parameters closely and delivering the fetus before severe hypoxia causes stillbirth or permanent brain damage.

Why IUGR Is Dangerous

IUGR is dangerous because it indicates an underlying pathology that is compromising the fetus. The risks include:

• Stillbirth: IUGR fetuses have a 4-8 times higher risk of stillbirth. The risk increases dramatically when Doppler flow becomes abnormal (absent or reversed end-diastolic flow in the umbilical artery).
• Hypoxic-ischemic encephalopathy (HIE): Chronic or acute hypoxia can cause brain damage, leading to cerebral palsy, developmental delays, seizures, and cognitive impairment.
• Perinatal asphyxia: The IUGR fetus has reduced reserves and may not tolerate labor, leading to acidosis and brain injury.
• Neonatal hypoglycemia: IUGR babies have limited glycogen stores and are prone to dangerous low blood sugar after birth.
• Hypothermia: IUGR babies have less subcutaneous fat and difficulty maintaining body temperature.
• Polycythemia: The body compensates for chronic hypoxia by producing excess red blood cells, which can cause blood thickening (hyperviscosity syndrome) and thrombosis.
• Necrotizing enterocolitis (NEC): Premature IUGR babies are at increased risk for this life-threatening intestinal condition.
• Long-term developmental problems: IUGR babies have higher rates of cognitive impairment, behavioral problems, and adult-onset diseases (cardiovascular disease, diabetes) — the 'fetal origins of adult disease' hypothesis.

The Standard of Care for IUGR Monitoring

When IUGR is suspected or diagnosed, the standard of care requires intensive fetal surveillance. ACOG and the Society for Maternal-Fetal Medicine (SMFM) guidelines include:

1. Serial growth ultrasounds: Every 2-4 weeks to monitor growth velocity. A single ultrasound showing small size is insufficient — the key is whether the fetus is growing at a normal rate or declining.

2. Doppler velocimetry: Umbilical artery Doppler is the primary surveillance tool for IUGR. It measures blood flow resistance in the umbilical artery. As placental insufficiency worsens: - Increased pulsatility index (PI): Early sign of increased resistance - Absent end-diastolic flow (AEDF): Worsening placental function — requires increased surveillance and consideration of delivery - Reversed end-diastolic flow (REDF): Severe placental dysfunction — requires delivery (usually by 32-34 weeks)

3. Biophysical profile (BPP) or modified BPP: Assessment of fetal movement, tone, breathing, amniotic fluid volume, and fetal heart rate (NST). Performed weekly or more frequently as needed.

4. Maternal monitoring: Monitoring for preeclampsia (blood pressure, urine protein, labs) — since preeclampsia is a common cause and complication of IUGR.

5. Delivery timing: The optimal delivery timing depends on the severity of IUGR, Doppler findings, and gestational age. Generally: - Normal Doppler: deliver at 37-39 weeks - Increased PI: deliver at 36-37 weeks - AEDF: deliver at 33-34 weeks - REDF: deliver at 30-32 weeks (or earlier if other signs of distress)

Doppler Ultrasound and Fetal Surveillance

Doppler velocimetry is the cornerstone of IUGR management. By measuring the blood flow velocity in the umbilical artery, Doppler provides a real-time assessment of placental function and fetal well-being.

The key parameter is the end-diastolic flow (EDF) in the umbilical artery: - Normal: Forward flow throughout the cardiac cycle (including diastole) - Increased PI: Forward flow but with increased resistance — early sign of placental insufficiency - Absent EDF: No forward flow during diastole — significant placental dysfunction. The risk of stillbirth increases substantially. ACOG recommends delivery at 33-34 weeks. - Reversed EDF: Blood flows backward during diastole — severe placental failure. The risk of stillbirth is very high. ACOG recommends delivery at 30-32 weeks (or earlier).

Failure to perform Doppler studies when IUGR is diagnosed or suspected, failure to recognize abnormal Doppler findings, or failure to deliver the fetus when Doppler flow becomes severely abnormal — all may constitute negligence.

When Failure to Diagnose IUGR Is Malpractice

Failure to diagnose or appropriately manage IUGR constitutes medical malpractice when:

- Risk factors were present but not screened: Maternal hypertension, preeclampsia, autoimmune disease, prior IUGR, or other risk factors should prompt growth monitoring. Failure to screen is negligence. - Growth was not monitored serially: A single normal ultrasound does not rule out IUGR if growth velocity subsequently declines. The standard of care requires serial growth assessments in at-risk pregnancies. - Declining growth was not recognized: If serial ultrasounds show declining growth velocity, the provider must investigate and diagnose IUGR. - Doppler studies were not performed: When IUGR is diagnosed, Doppler velocimetry is the standard of care. Failure to perform Doppler is a deviation. - Abnormal Doppler was not acted upon: Absent or reversed end-diastolic flow requires delivery. Failure to deliver when Doppler flow is severely abnormal may constitute negligence. - Fetal surveillance was inadequate: BPP or modified BPP should be performed regularly. Failure to monitor fetal well-being is a deviation. - Delivery was delayed: When IUGR is severe and the fetus is at risk, delivery must be timed appropriately. Premature delivery risks complications, but delayed delivery risks stillbirth and brain injury. The standard of care balances these risks based on gestational age, Doppler findings, and BPP results.

Expert testimony from a board-certified obstetrician or maternal-fetal medicine specialist is required to establish the standard of care and demonstrate how it was breached.

Timing of Delivery in IUGR Pregnancies

The timing of delivery in IUGR pregnancies is one of the most critical decisions. The provider must balance the risks of prematurity (respiratory distress syndrome, intraventricular hemorrhage, NEC, cerebral palsy) against the risks of continued intrauterine stay (stillbirth, HIE, worsening placental insufficiency).

ACOG and SMFM provide the following guidance: - Normal Doppler, no other complications: Deliver at 37-39 weeks - Increased PI: Deliver at 36-37 weeks - Absent end-diastolic flow: Deliver at 33-34 weeks (after corticosteroids for fetal lung maturity) - Reversed end-diastolic flow: Deliver at 30-32 weeks (or earlier if abnormal BPP or other signs of distress) - Abnormal BPP or fetal distress at any gestational age: Deliver immediately

The administration of antenatal corticosteroids (betamethasone or dexamethasone) is the standard of care when delivery is anticipated before 34 weeks — it accelerates fetal lung maturity and reduces the risk of respiratory distress syndrome, intraventricular hemorrhage, and NEC. Failure to administer corticosteroids when preterm delivery is planned may itself constitute negligence.

Consequences of Missed IUGR

When IUGR is not diagnosed and managed appropriately, the consequences can be catastrophic: - Stillbirth: The most devastating outcome. IUGR fetuses with abnormal Doppler flow are at very high risk of stillbirth. - Hypoxic-ischemic encephalopathy (HIE): Chronic or acute hypoxia causes brain damage. HIE can lead to cerebral palsy, developmental delays, seizures, and cognitive impairment. - Cerebral palsy: Perinatal hypoxia from placental insufficiency is a known cause of cerebral palsy, particularly in IUGR babies who have reduced reserves. - Neonatal death: IUGR babies have higher neonatal mortality rates, particularly from respiratory complications, NEC, and infection. - Long-term developmental problems: Even babies who survive may have cognitive impairment, behavioral problems, and increased risk of adult-onset diseases.

New York Statute of Limitations

Under CPLR § 214-a, the statute of limitations is 2.5 years from the date of the negligent act. The infancy toll (CPLR § 208) extends the child's deadline to age 20. Parents' economic claims must be filed within 2.5 years. For municipal hospital claims, a Notice of Claim must be filed within 90 days (GML § 50-e). [Link to: /birth-injury/statute-of-limitations]

Frequently Asked Questions

The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.